Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction

Myocardial fibrosis, measured using magnetic resonance extracellular volume (ECV), associates with adverse outcome in heart failure with preserved ejection fraction (HFpEF). In the PIROUETTE (The Pirfenidone in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction) trial, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lewis, Gavin A., Rosala-Hallas, Anna, Dodd, Susanna, Schelbert, Erik B., Williams, Simon G., Cunnington, Colin, McDonagh, Theresa, Miller, Christopher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2022
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797453/
https://www.ncbi.nlm.nih.gov/pubmed/35138474
http://dx.doi.org/10.1007/s10554-022-02544-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797453/
https://www.ncbi.nlm.nih.gov/pubmed/35138474
http://dx.doi.org/10.1007/s10554-022-02544-9

Ejemplares similares